Literature DB >> 25647962

Using time-driven activity-based costing to identify value improvement opportunities in healthcare.

Robert S Kaplan, Mary Witkowski, Megan Abbott, Alexis Barboza Guzman, Laurence D Higgins, John G Meara, Erin Padden, Apurva S Shah, Peter Waters, Marco Weidemeier, Sam Wertheimer, Thomas W Feeley.   

Abstract

As healthcare providers cope with pricing pressures and increased accountability for performance, they should be rededicating themselves to improving the value they deliver to their patients: better outcomes and lower costs. Time-driven activity-based costing offers the potential for clinicians to redesign their care processes toward that end. This costing approach, however, is new to healthcare and has not yet been systematically implemented and evaluated. This article describes early time-driven activity-based costing work at several leading healthcare organizations in the United States and Europe. It identifies the opportunities they found to improve value for patients and demonstrates how this costing method can serve as the foundation for new bundled payment reimbursement approaches.

Entities:  

Mesh:

Year:  2014        PMID: 25647962

Source DB:  PubMed          Journal:  J Healthc Manag        ISSN: 1096-9012


  44 in total

1.  Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing.

Authors:  Nikhil G Thaker; Thomas J Pugh; Usama Mahmood; Seungtaek Choi; Tracy E Spinks; Neil E Martin; Terence T Sio; Rajat J Kudchadker; Robert S Kaplan; Deborah A Kuban; David A Swanson; Peter F Orio; Michael J Zelefsky; Brett W Cox; Louis Potters; Thomas A Buchholz; Thomas W Feeley; Steven J Frank
Journal:  Brachytherapy       Date:  2016-02-23       Impact factor: 2.362

2.  The Cost of Penicillin Allergy Evaluation.

Authors:  Kimberly G Blumenthal; Yu Li; Aleena Banerji; Brian J Yun; Aidan A Long; Rochelle P Walensky
Journal:  J Allergy Clin Immunol Pract       Date:  2017-09-22

Review 3.  Activity-Based Costing.

Authors:  Faryan Jalalabadi; Allen L Milewicz; Sohail R Shah; Larry H Hollier; Edward M Reece
Journal:  Semin Plast Surg       Date:  2018-10-22       Impact factor: 2.314

4.  Value-based Healthcare: Applying Time-driven Activity-based Costing in Orthopaedics.

Authors:  Aakash Keswani; Nicole Sheikholeslami; Kevin J Bozic
Journal:  Clin Orthop Relat Res       Date:  2018-12       Impact factor: 4.176

5.  Defining the Costs of Reusable Flexible Ureteroscope Reprocessing Using Time-Driven Activity-Based Costing.

Authors:  Dylan Isaacson; Tessnim Ahmad; Ian Metzler; David T Tzou; Kazumi Taguchi; Manint Usawachintachit; Samuel Zetumer; Benjamin Sherer; Marshall Stoller; Thomas Chi
Journal:  J Endourol       Date:  2017-09-20       Impact factor: 2.942

6.  Estimating Direct Cost of Cystic Fibrosis Care Using Irish Registry Healthcare Resource Utilisation Data, 2008-2012.

Authors:  Abaigeal D Jackson; Andrew L Jackson; Godfrey Fletcher; Gerardine Doyle; Mary Harrington; Shijun Zhou; Fiona Cullinane; Charles Gallagher; Edward McKone
Journal:  Pharmacoeconomics       Date:  2017-10       Impact factor: 4.981

Review 7.  Using Time-Driven Activity-Based Costing to Demonstrate Value in Perioperative Care: Recommendations and Review from the Society for Perioperative Assessment and Quality Improvement (SPAQI).

Authors:  Olivia Allin; Richard D Urman; Angela F Edwards; Jeanna D Blitz; Kurt J Pfeifer; Thomas W Feeley; Angela M Bader
Journal:  J Med Syst       Date:  2019-12-11       Impact factor: 4.460

Review 8.  Emergent Challenges in Determining Costs for Economic Evaluations.

Authors:  Josephine C Jacobs; Paul G Barnett
Journal:  Pharmacoeconomics       Date:  2017-02       Impact factor: 4.981

9.  Communicating Value in Health Care Using Radar Charts: A Case Study of Prostate Cancer.

Authors:  Nikhil G Thaker; Tariq N Ali; Michael E Porter; Thomas W Feeley; Robert S Kaplan; Steven J Frank
Journal:  J Oncol Pract       Date:  2016-08-30       Impact factor: 3.840

10.  Time-driven activity-based costing of a novel form of CT-guided high-dose-rate brachytherapy intraoperative radiation therapy compared with conventional breast intraoperative radiation therapy for early stage breast cancer.

Authors:  Greg Suralik; Sonali Rudra; Sunil W Dutta; Jialu Yu; Jason C Sanders; Michael D Schad; Einsley-Marie Janowski; Lucy Su; Bruce Libby; Shayna L Showalter; Jennifer M Lobo; Timothy N Showalter
Journal:  Brachytherapy       Date:  2020-03-28       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.